首页> 外国专利> New disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds useful in the treatment of chemokine-mediated pathologies

New disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds useful in the treatment of chemokine-mediated pathologies

机译:可用于治疗趋化因子介导的病理学的新的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物

摘要

Disubstituted compound of 3,4-diamino-3-cyclobutene-1,2-dione which responds to the following general formula (I) or one of its pharmaceutically acceptable salts or solvates: ** Formula ** where R 1 represents an atom of hydrogen or a methyl; R2 represents a ring of five atoms selected from the following structures (1), (2), (3) and (4): ** Formula ** in which R5, R7a, X and X 'have the meaning to be given later; R3 represents an aromatic or heteroaromatic ring selected from the group consisting of the rings that respond to the following formulas (a) to (o): ** Formula ** in which R7, R7a, Y and Z have the meaning to be given later, specifying that the rings (a) to (o) may eventually carry several R7 groups, identical or different, the total number of such groups R7 being at most equal to the number of substitutable atoms in the ring; R4 represents an aromatic or heteroaromatic ring selected from the group consisting of the rings that respond to the following formulas (p) to (z) and (aa) to (ak): ** Formula ** in which R7, R8, R9 , R10, R11, R12, R13, R14 and R15 have the meaning that will be given later; R5 represents a hydrogen atom, a fluorine atom, an alkyl radical of 1 to 5 carbon atoms or a fluorinated or perfluorinated alkyl radical of 1 to 5 carbon atoms; R6 represents a hydrogen atom, a -COOtBu radical or a -COOBn radical; R7 represents a halogen, a radical -R16, -CF3, -COR16, -OR16, -NR16R17, -NO2, -CN, -SO2R16, -SO2NR16R17, -NR16COR17, -CONR16R17, -NR16CO2R17 or -CO2R16; R7a represents a hydrogen atom or an alkyl radical of 1 to 5 carbon atoms; R8 represents a hydrogen atom, a halogen atom, a radical -OH, a radical -SH, -CONHOR16, -CONR16OH, -NR16R17, -SO3H, -OCOR16, -NHSO2R16, -SO2NR16R17, -NHCOR16, -CONR16R17, - NR16CO2R17, -NHSO2NR16R17, -CO2R16, pyrrolyl, imidazolyl, triazolyl or tetrazolyl; R9, R10, R11 and R12 are identical or different and are independently selected from the group consisting of a hydrogen, a halogen atom, an alkyl radical, alkoxy, -CF3, -OCF3, -OH, -NO2, -CN, - SO2R16, -SO2NR16R17, -NR16COR17, -NR16CO2R17, -CONR16R17, -COR16 or -CO2R16; or also, when two of the radicals R9, R10, R11 and R12 are in ortho position in an aromatic or heteroaromatic ring selected from the group consisting of the rings that respond to formulas (p) to (z) and (aa) a (ak) above, then they can form together, with the joining together, an aryl, heteroaryl, cycloalkyl or heterocycloalkyl ring; R13 and R14 are identical or different and are independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl radical, -CF3, -OCF3, -OH, -SH, -CN, -SO2R16, -SO2NR16R17 , -NHSO2NR16R17, -NR16R17, -NR16CONR16R17, -NR16COR17, -NR16CO2R17, -CONR16R17, -COR16 or -CO2R16; R15 represents a hydrogen atom, a radical -OH, -SO2R16, -COR16, -CO2R16, aryl, heteroaryl, arylalkyl, heteroarylalkyl, alkyl, cycloalkyl or cycloalkylalkyl; R16 and R17 are identical or different and are independently selected from the group consisting of a hydrogen atom, an aryl radical, heteroaryl, arylalkyl, heteroarylalkyl, alkyl, fluorinated alkyl of 1 to 5 carbon atoms, cycloalkyl or cycloalkylalkyl, a group - CH2COOR18 in which R18 represents an alkyl radical of 1 to 5 carbon atoms, or also, when R16 and R17 are carried by the same nitrogen atom, they form a heterocycle having between 3 and 7 links and eventually carrying one or two heteroatoms selected from oxygen, sulfur and nitrogen, in addition to the common nitrogen atom by which they are carried, said heterocycle may be substituted by an alkyl group of 1 to 5 carbon atoms or a -COOR18 group in which R18 represents an alkyl radical of 1 to 5 carbon atoms; X and X ', identical or different, represent an oxygen atom, a sulfur atom or a nitrogen atom substituted by a radical R6; Y represents an oxygen atom, a sulfur atom or a nitrogen atom substituted by a radical R15, and Z represents a carbon or nitrogen atom.
机译:3,4-二氨基-3-环丁烯-1,2-二酮的二取代化合物,其响应以下通式(I)或其药学上可接受的盐或溶剂化物之一:**式**,其中R 1代表一个原子氢或甲基; R 2代表选自以下结构(1),(2),(3)和(4)的五个原子的环:**式**,其中R 5,R 7a,X和X'具有稍后给出的含义。 ; R 3表示选自对下列式(a)至(o)作出反应的环的芳族或杂芳族环:**式**,其中R 7,R 7a,Y和Z具有稍后给出的含义。 ,规定环(a)至(o)最终可以带有几个相同或不同的R 7基团,这些基团R 7的总数最多等于环中可取代的原子数; R 4代表选自对以下式(p)至(z​​)和(aa)至(ak)作出反应的环的芳族或杂芳族环:**式**其中R7,R8,R9, R10,R11,R12,R13,R14和R15具有稍后将给出的含义; R 5表示氢原子,氟原子,碳数1〜5的烷基或碳数1〜5的氟或全氟烷基。 R6代表氢原子,-COOtBu基或-COOBn基; R7代表卤素,基团-R16,-CF3,-COR16,-OR16,-NR16R17,-NO2,-CN,-SO2R16,-SO2NR16R17,-NR16COR17,-CONR16R17,-NR16CO2R17或-CO2R16; R 7a表示氢原子或1〜5个碳原子的烷基。 R 8代表氢原子,卤素原子,-OH,-SH,-CONHOR16,-CONR16OH,-NR16R17,-SO3H,-OCOR16,-NHSO2R16,-SO2NR16R17,-NHCOR16,-CONR16R17,-NR16CO2R17, -NHSO2NR16R17,-CO2R16,吡咯基,咪唑基,三唑基或四唑基; R 9,R 10,R 11和R 12相同或不同,并且独立地选自氢,卤素原子,烷基,烷氧基,-CF 3,-OCF 3,-OH,-NO 2,-CN,-SO 2 R 16。 ,-SO2NR16R17,-NR16COR17,-NR16CO2R17,-CONR16R17,-COR16或-CO2R16;或者,当基团R9,R10,R11和R12中的两个在芳族或杂芳族环中的邻位时,所述芳族或杂芳族环选自对式(p)至(z​​)和(aa)a进行响应的环ak),那么它们可以一起形成芳基,杂芳基,环烷基或杂环烷基环; R 13和R 14相同或不同,并且独立地选自氢原子,卤素原子,烷基,-CF 3,-OCF 3,-OH,-SH,-CN,-SO 2 R 16,-SO 2 NR 16 R 17,- NHSO2NR16R17,-NR16R17,-NR16CONR16R17,-NR16COR17,-NR16CO2R17,-CONR16R17,-COR16或-CO2R16; R15代表氢原子,基团-OH,-SO2R16,-COR16,-CO2R16,芳基,杂芳基,芳基烷基,杂芳基烷基,烷基,环烷基或环烷基烷基; R16和R17相同或不同,并且独立地选自氢原子,芳基,杂芳基,芳基烷基,杂芳基烷基,烷基,具有1至5个碳原子的氟化烷基,环烷基或环烷基烷基,其中的基团-CH 2 COOR 18其中R18代表1至5个碳原子的烷基,或者,当R16和R17被相同的氮原子携带时,它们形成具有3至7个连接的杂环,并最终携带一个或两个选自氧,硫的杂原子氮和氮,除了它们所带有的普通氮原子外,还可以被1-5个碳原子的烷基或-COOR18基团取代,其中R18代表1-5个碳原子的烷基。 X和X′相同或不同,表示被基团R6取代的氧原子,硫原子或氮原子。 Y表示被基团R 15取代的氧原子,硫原子或氮原子,Z表示碳或氮原子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号